Detalles de la búsqueda
1.
JTZ-951, an HIF prolyl hydroxylase inhibitor, suppresses renal interstitial fibroblast transformation and expression of fibrosis-related factors.
Am J Physiol Renal Physiol
; 318(1): F14-F24, 2020 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31630548
2.
JTZ-951 (enarodustat), a hypoxia-inducible factor prolyl hydroxylase inhibitor, improves iron utilization and anemia of inflammation: Comparative study against recombinant erythropoietin in rat.
Eur J Pharmacol
; 898: 173990, 2021 May 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33657422
3.
JTZ-951 (enarodustat), a hypoxia-inducibe factor prolyl hydroxylase inhibitor, stabilizes HIF-α protein and induces erythropoiesis without effects on the function of vascular endothelial growth factor.
Eur J Pharmacol
; 859: 172532, 2019 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31301309
4.
JTE-852, a novel spleen tyrosine kinase inhibitor, blocks antigen-induced allergic reactions in rats.
J Vet Med Sci
; 80(3): 465-472, 2018 Mar 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-29375080
5.
JTE-852, a novel spleen tyrosine kinase inhibitor, blocks mediator secretion from mast cells with immunoglobulin E crosslinking.
Eur J Pharmacol
; 801: 1-8, 2017 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28259713
6.
JTE-852, a novel spleen tyrosine kinase inhibitor, blocks immunoglobulin G-mediated cellular responses and autoimmune reactions in vivo.
Life Sci
; 191: 166-174, 2017 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29056373
Resultados
1 -
6
de 6
1
Próxima >
>>